Richard Pilnik

Richard Dal Pilnik currently works at BIAL-Portela & Cia SA, as Non-Executive Director, Business Council for International Understanding, as Director, The Fuqua School of Business, as Director-Emeritus, Vigor Medical Systems, Inc., as Director, WCG Clinical, Inc., as Independent Director from 2021, RDP Consulting, Inc., as Director, Lumanity, Inc., as Director, and Lumanity, Inc. (United States), as Director.
Mr. Pilnik also formerly worked at Chiltern International Ltd., as Chairman from 2016 to 2017, Elan Corp.
Plc, as Independent Non-Executive Director from 2012 to 2014, Elan Pharmaceuticals LLC, as Director, Certara USA, Inc., as Director, Nusirt Sciences, Inc., as Director, Islet Sciences, Inc., as Director from 2015 to 2016, DiaMedica Therapeutics, Inc., as Director in 2025, Eli Lilly & Co., as Chief Marketing Officer & Group Vice President from 2006 to 2008, Quintiles Transnational Corp., as President-Commercial Solutions & Executive VP from 2012 to 2014, and Innovex Ltd., as President.
Mr. Pilnik received his undergraduate degree from Duke University and Masters Business Admin degree from Kellogg School of Management.